Clinical Utility of the Risperidone Formulations in the Management of Schizophrenia

Neuropsychiatric Disease and Treatment - New Zealand
doi 10.2147/ndt.s14385
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

The Influence of Switching From Oral Risperidone to Risperidone Long-Acting Injection on the Clinical Symptoms and Cognitive Function in Schizophrenia

Therapeutic Advances in Psychopharmacology
2011English

Risperidone vs Olanzapine in Treatment of Schizophrenia: A Double Blind Clinical Trial

MOJ Addiction Medicine & Therapy
2018English

Clinical Utility of Pharmacogenomics in the Management of Hepatitis C

Pharmacogenomics and Personalized Medicine
Molecular MedicinePharmacology
2014English

Risperidone Versus Placebo for Schizophrenia

Cochrane Database of Systematic Reviews
2016English

A Cost Utility Analysis of CYP2D6 Pharmacogenetic Guided Dosing Versus Standard Dosing of Risperidone for Treatment of Schizophrenia

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2014English

Do We Have Any Solid Evidence of Clinical Utility About the Pathophysiology of Schizophrenia?

World Psychiatry
PsychiatryMental HealthPsychiatric Mental Health
2011English

Clinical Utility of Electrocochleography in the Diagnosis and Management of Ménière's Disease

Otology and Neurotology
MedicineOtorhinolaryngologySensory SystemsNeurology
2010English

Risperidone for Individuals With Refractory Schizophrenia

Clinical Medicine Insights: Therapeutics
MedicinePharmacologyPharmaceutical Science
2010English

Pmh42 - Cost-Utility Analysis of Cariprazine Compared to Risperidone Among Patients With Negative Symptoms of Schizophrenia in Selected Nordic Countries

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy